Mori fructus-derived extracellular vesicle-like nanoparticles regulate dyslipidemia and prevent atherosclerosis progression via miRNAs
{{output}}
Background: Atherosclerosis, driven majorly by dyslipidemia, is a major risk factor for acute and chronic cardiovascular diseases. Hence, the development of bioactive products that can regulate lipid metabolism and prevent the on... ...
